References
- PliszkaSfor the AACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200735180184
- American Academy of Pediatrics, Subcommittee on Attention-Deficit- Hyperactivity Disorder Committee on Quality ImprovementClinical Practice guideline Treatment of the school-age child with attention-deficit/hyperactivity disorderPediatrics20011081033104411581465
- LopezFAADHD: New Pharmacological treatments on the horizonJ Dev Behav Pediatr20062741041617041279
- JasinskiDRKrishnanSHuman pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusersJ Psychopharmacol20092341041818635707
- FaraoneSVSergeantJGillbergCBiedermanJThe worldwide prevalence of ADHD: is it an American conditionWorld Psychiatry2003210411316946911
- KesslerRCAdlerLBarkleyRThe prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey replicationAm J Psychiatry200616371672316585449
- WilensTEBiedermanJSpencerTJAttention deficit/hyperactivity disorder across the lifespanAnnu Rev Med20025311313111818466
- SurmanCBHWeislerRHThe state of the art of treatment for pediatric and adolescent ADHD http://www.medscape.com/viewarticle/537383Accessed 2010 March 31
- ConnorDFSteingardRJNew formulations of stimulants for attention- deficit hyperactivity disorder: therapeutic potentialCNS Drugs2004181011103015584770
- BiedermanJBoellnerSWChildressALopezFAKrishnanSZhangYLisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo- controlled, crossover analog classroom studyBiol Psychiatry20076297097617631866
- McGoughJJBiedermanJGreenhillLLPharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adder-allJ Am Acad Child Adolesc Psychiatry20034268469112921476
- EliaJEasleyCKirkpatrickPLisdexamfetamine dimesylateNat Rev Drug Discov2007634334417539056
- http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4356b1-02-Purdue.pdfAccessed 2009 November 7
- FindlingRLEvolution of the treatment of attention-deficit/hyperactivity disorder in children: a reviewClin Ther20083094295118555941
- BiedermanJKrishnanSZhangYMcGoughJJFindlingRLEfficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyClin Ther20072945046317577466
- NajibJThe Efficacy and Safety Profile of Lisdexamfetamine Dimesylate, a Prodrug of d-Amphetamine, for the Treatment of Attention- Deficit/Hyperactivity Disorder in Children and AdultsClin Ther20093014217519243715
- Vyvanse (lisdexamfetamine dimesylate). [package insert]Wayne, PAShire US Inc2008 http://www.vyvanse.com/index-child.aspAccessed 2010 March 31
- KrishnanSZhangYRelative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: A single-dose, crossover pharmacokinietic studyJ Clin Pharmacol20084829330218285619
- Adderall XR mixed amphetamine salts extended release) capsules. [package insert]Wayne, PAShire US Inc2007
- KrishnanSMoncriefSAn evaluation of the cytochrome p450 inhibition potential of Lisdexamfetamine in liver microsomesDrug Metab Dispos20073518018417035599
- MadaanVLisdexamfetamine Dimesylate For Childhood ADHDDrugs Today20084431932418548134
- JasinskiDKrishnanSPharmacokinetics of oral lisdexamfetamine dimesylate (LDX;NRP104) vs d-amphetamine in healthy adults with a history of stimulant abuse2006 US Psychiatric and Mental Health Congress2006 November 17–19New Orleans, LA, USA
- JasinskiDKrishnanSA double-blind, randomized, placebo- and active-controlled, 6-period crossover study to evaluate the likeability, safety, and abuse potential of lisdexamfetamine dimesylate (LDX) in adult stimulant abusers2006 US Psychiatric and Mental Health Congress2006 November 17–19New Orleans, LA, USA
- SpillerHAGriffithJRAndersonDLPoison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamineAnn Pharmacother2008421142114318594051
- O’KeefeLECGs for all ADHD patients? AAP-AHA release joint clarification on AHA recommendationAAP News2008291